Pain and neuropathy measures | Pretreatment baseline | V2 | V3 | V4 | V5 |
---|---|---|---|---|---|
Total McGill pain location Median (IQR) (−/45) | 21.3±15.0 23 (7–36) | 19.1±15.9 13 (5–36) | 7.5±7.5* 5 (2–11)* | 6.5±6.4* 5 (2–9)* | 5.9±5.3* 5 (3–8)* |
McGill pain score (−/5) | 2.1±0.9 | 1.9±1.0 | 1.7±1.1ª | 1.5±1.0* | 1.5±1.0* |
DN4 Median (IQR) (−/10) | 3.0±1.8 3 (2–4) | 2.8±2.1 3 (1–4) | 2.6±1.9 2 (1–4) | 2.8±2.1 3 (1–4) | 2.8±2.1 3 (1–4) |
Positive symptoms (DN4) Median (IQR) (−/6) | 2.0±1.4 2 (1–3) | 1.7±1.5 1 (1–3) | 1.5±1.4# 1 (0–2) | 1.4±1.4^ 1 (0–2) | 1.4±1.2** 1 (0–2) |
*p<0.0001, ªp=0.007, #p=0.03, ^p=0.006, **p=0.004.
DN4, Douleur Neuropathique 4; V2, visit 2.